Molecules that block virus entry by interfering with the actions of the viral fusion proteins are of primary concern in the search of antiviral drugs. We present here the synthesis and the antiviral activities of lipid-oligonucleotide conjugates (Lipoquads) forming a highly stable tetramolecular parallel Gquadruplex. We show that these molecules block HIV-1 and HIV-2 entry with submicromolar activities, demonstrating the great advantage of targeting both viral Envelope glycoprotein and lipids rafts, key platform in virus entry.
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Name
Sequence 5'-3' G-Quadruplex G-quadruplex Self-assembly
LOC

G4-LOC
Native PAGE separation and circular dichroism assess G4 formation
The G4-LOC are highly stable molecules
Electromobility-shift assay demonstrates that our G4-LOC is bound by recombinant gp120 in vitro
Virus attachment/entry inhibition
G4-LOC are potent inhibitors of HIV-1 in cell cultures
The G4-LOC do neither target virus assembly nor virus production Our G4-LOC do not affect HeLa cells viability at 20µM, as also seen with TZB-bl, SupT1, ACH-2 and 293T cells Recombinant NL4.3-ren supernatants were incubated with 100nM of GQvir17-lino for 3h and next diluted 30 times to infect SupT1 cells, which therefore diluted the compounds below EC50 levels (e.g. 3nM). SupT1 cells were infected in parallel with the dilution control (3nM) and direct inhibition of infection was performed as a positive control with 100nM of G4-LOC. This assay produced 50% of neutralized viruses when incubated with the compounds, suggesting their direct and persistent binding to the virus.
Viral entry inhibition is demonstrated by infecting SupT1 cells with HIV recombinant virus pseudo-typed with the G protein of VSV (NL4.3-Δenv-VSV-Luc ), which enters host cells independently of cell receptors. VSV-pseudo-typed virus infection was not affected by the presence of neither GQvir17-lino nor the control seq17-lino, while 100 nM of GQvir17-lino inhibited HIV NL4.3 infection with an efficiency of around 70%.
